Sharon Larkin
Direttore/Membro del Consiglio presso SENSEONICS HOLDINGS, INC.
Patrimonio netto: 221 047 $ in data 30/04/2024
Posizioni attive di Sharon Larkin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SENSEONICS HOLDINGS, INC. | Direttore/Membro del Consiglio | 08/12/2021 | - |
| Independent Dir/Board Member | 08/12/2021 | - | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Direttore/Membro del Consiglio | 01/12/2021 | - |
Storia della carriera di Sharon Larkin
Precedenti posizioni note di Sharon Larkin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Direttore Amministrativo | 25/04/2017 | 01/01/2020 |
| Ufficiale delle Risorse Umane | 25/04/2017 | 01/01/2020 | |
| ABBOTT LABORATORIES | Ufficiale delle Risorse Umane | 01/09/2011 | 01/09/2015 |
Formazione di Sharon Larkin
| Georgia Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director/Board Member | 2 |
| Human Resources Officer | 2 |
| Chief Administrative Officer | 1 |
Settori
| Health Technology | 3 |
| Electronic Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Aziende private | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Technology |
- Borsa valori
- Insiders
- Sharon Larkin
- Esperienza
